Innate Pharma SA Files 6-K
Ticker: IPHYF · Form: 6-K · Filed: Mar 6, 2024 · CIK: 1598599
| Field | Detail |
|---|---|
| Company | Innate Pharma SA (IPHYF) |
| Form Type | 6-K |
| Filed Date | Mar 6, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 6-K, foreign-private-issuer
TL;DR
Innate Pharma SA filed a 6-K on 3/6/24, confirming its French HQ and 20-F filing status. No major news.
AI Summary
Innate Pharma SA filed a Form 6-K on March 6, 2024, reporting its status as a foreign private issuer. The filing confirms its principal executive office is located at 117 Avenue de Luminy, Marseille, France, and it files annual reports under Form 20-F. No specific financial or operational updates were detailed in this particular filing.
Why It Matters
This filing serves as a routine update for investors and regulatory bodies, confirming the company's reporting status and principal place of business.
Risk Assessment
Risk Level: low — This is a routine administrative filing with no new material financial or operational information that would typically impact risk.
Key Players & Entities
- Innate Pharma SA (company) — Registrant
- March 6, 2024 (date) — Filing date
- 117 Avenue de Luminy, Marseille, France (location) — Principal executive office
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report form
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, confirming the company's reporting status and principal place of business.
When was this Form 6-K filed?
The Form 6-K was filed on March 6, 2024.
Where is Innate Pharma SA's principal executive office located?
Innate Pharma SA's principal executive office is located at 117 Avenue de Luminy, Marseille, France.
Does Innate Pharma SA file its annual reports under Form 20-F or Form 40-F?
Innate Pharma SA indicates it files annual reports under cover of Form 20-F.
What is the Commission File Number for Innate Pharma SA?
The Commission File Number for Innate Pharma SA is 001-39084.
Filing Stats: 281 words · 1 min read · ~1 pages · Grade level 10.3 · Accepted 2024-03-06 06:00:41
Filing Documents
- a6kincorporated-iphx240603.htm (6-K) — 13KB
- exhibit991-240306fpi.htm (EX-99.01) — 20KB
- 0001598599-24-000007.txt ( ) — 35KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. INNATE PHARMA S.A. Date March 6, 2024 By s HERVE BRAILLY Name Herv Brailly Title Chairman of the Executive Board and Chief Executive Officer